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Abstract 
Purpose: To produce and characterize silver nanoparticles using Candida albicans and evaluate its 
antibacterial properties. 
Methods: Extracellular silver nanoparticles were biosynthesized using C. albicans. The biomass 
obtained from cultures of C. albicans was used to synthesize silver nanoparticles in 1.5 mM silver nitrate 
solution. Characterization of the biosynthesized nanoparticles was carried out using ultraviolet (UV)-
visible spectrometry and scanning electron microscopy (SEM). The antibacterial properties of the 
nanoparticles were determined by agar disc diffusion method against Escherichia coli and 
Staphylococcus aureus.  
Results: Incubation of C. albicans with silver nitrate solution produced silver nanoparticles after 2 – 4 h 
as evidenced by change in the color of the reaction mixture. The formation of silver nanoparticles was 
confirmed by UV-visible spectroscopy which showed absorption peak between 300 – 800 nm, being the 
characteristic wavelength range of silver nanoparticles. SEM revealed the varying morphology of the 
nanoparticles which had a size range of 20 – 80 nm. Furthermore, the nanoparticles showed significant 
antimicrobial activity (p < 0.05).  
Conclusion: The biosynthesized silver nanoparticles hold some promise for various industrial 
applications, including drug delivery.  
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The use of nanotechnology in medicine is set to 
spread rapidly. In the last decades, the treatment 
of bacterial infections has become increasingly 
complicated due to their resistance mechanisms. 
This has resulted in severe debilitating and even 
life-threatening infections; thus this situation is 
driving the search for novel antibacterial agents 
[1]. 
 
Metal nanoparticles have proved to be effective 
against microorganisms. The broad-spectrum 
antimicrobial properties of silver encourage its 
widespread use [1,2]. Silver nanoparticles are of 
particular interest due to their distinctive physical, 
chemical and biological properties [3,4].  Silver 
nanoparticles have proved to be most effective 
metallic nanoparticles as they have potent 
antimicrobial efficacy against various pathogenic 
microorganisms including bacteria such as 
Escherichia coli, Staphylococcus aureus, 
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Staphylococcus epidermis, Leuconostoc 
mesenteroides, Bacillus subtilis, Klebsiella 
mobilis, and Klebsiella pneumonia. Silver 
nanoparticles are more effective against 
microorganisms due to high surface area to 
volume ratio so that a large proportion of silver 
atoms are in direct contact with their 
environment. The antibacterial activity of silver 
nanoparticles against Gram negative and Gram 
positive bacteria have been established, but the 
mechanism of action of silver nanoparticles has 
not been completely understood [2,3,5-8].   
 
Recently, researchers found that microorganisms 
have been explored as potential ecofriendly 
nanofactories for the synthesis of silver 
nanoparticles. Biosynthesis of nanoparticles has 
received considerable attention due to better 
control over size distribution of nanoparticles and 
the environmental toxicity [5,9,10]. The potential 
application of microorganisms in silver 
nanoparticles synthesis has been explored that 
can be applied to many fields and more 
specifically to biomedicine. Thus, significant 
efforts have been directed towards finding an 
inexpensive and environment-friendly method for 
nanoparticle synthesis. Several lines of evidence 
demonstrated the biosynthesis of extracellular 
silver nanoparticles utilizing many ubiquitous 
fungal species. Fungi especially yeast present a 
suitable option for large-scale green 
nanoproduction. The mechanism of nanoparticle 
production using fungi is different; fungi secrete 
large amounts of enzymes which are used to 
reduce silver ions to metal nanoparticles 
[3,11,12]. The mycosynthesis of silver 
nanoparticles was carried out from Candida 
albicans and their antibacterial activity against E. 






In this study 15 clinical isolates of Candida 
albicans were isolated and identified from 
immunocompromised patients. Standard strain of 
C. albicans ATCC 14053, Escherichia coli ATCC 
39403 and Staphylococcus aureus ATCC 25923 
were employed.  
 
Biosynthesis of silver nanoparticles  
 
The characterized isolates of C. albicans and C. 
albicans ATCC 14053 were plated out on 
Sabouraud Dextrose Agar (SDA, Merck, 
Germany) containing 3.5 mM silver nitrate and 
incubated at 37 °C for 24 h. The colonies 
obtained were inoculated in 250 ml Sabouraud 
Dextrose Broth (SDB, Merck, Germany) and 
incubated at 37 °C on shaking incubator at 200 
rpm for 24 h. After incubation the cells were 
separated by centrifugation at 6,000 rpm for 15 
min and washed 3 times with 50 mM phosphate 
buffer (pH 7.0). Two g of wet biomass was 
collected and then added in 1.5 mM 50 ml silver 
nitrate solution and incubated at 37 °C on 
shaking incubator at 250 rpm in dark for 48 h. 
The silver nitrate reduced to silver nanoparticles 
shows change in color of silver nitrate from 
colorless to brown was harvested by 
centrifugation at 6,000 rpm for 6 min. The 
production of silver nanoparticles were analyzed 
by UV–visible spectrophotometric analysis and 
subjected to scanning electron microscopy 
(SEM) [3]. 
 
Characterization of silver nanoparticles  
 
The synthesis of silver nanoparticles was 
monitored by UV–visible spectroscopy 
(Shimadzu, UV Pharma spec 1700 with a 
resolution of 0.72 nm) by recording the spectra 
between 300 – 800 nm. The cell biomass of 
silver nitrate at time zero served as control. The 
produced silver nanoparticles were subjected to 
SEM (JEOL JSM 6360, Japan) and the images 
of nanoparticles were taken. The exact size and 
particle size distributions of silver nanoparticles 
were also determined by particle size analysis. 
 
Antibacterial activity of silver nanoparticles 
 
Silver nanoparticles synthesized from C. albicans 
were tested for antibacterial activity against 
pathogenic microorganisms E. coli ATCC 39403 
and S. aureus ATCC 25923. The antibacterial 
activity of silver nanoparticles was tested by the 
agar disc diffusion method according to the 
Clinical and Laboratory Standards Institute 
protocol (M02 – A11) for bacteria with some 
slight modification. Both bacteria were cultured 
on Nutrient Agar (NA, Merck, Germany) and then 
passaged twice to ensure viability and purity.  
 
Stock inoculum suspensions of the E. coli and S. 
aureus were prepared by picking colonies from 
24 h cultures grown on NA at 37 °C and 
suspending in 5 ml of sterile saline (0.85 %) v/v 
NaCl. The suspension was adjusted with the aid 
of spectrophotometry at a wavelength of 625 nm 
to achieve turbidity equivalent to 0.5 McFarland 
standard, i.e., approximately (1 – 2) × 108 colony-
forming units /ml). The inocula were spread on 
Mueller Hinton Agar using a sterile cotton swab. 
The culture plates were kept to dry at room 
temperature for 15 min. For the next step 0, 10, 
20 and 50 µl of the sterile silver nanoparticles 
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were impregnated on separate paper disks and 
put on the surface of cultured media. 
Tetracycline was used as positive control. 
Eventually the cultured plates were incubated at 
37 °C for 24 h and then the diameter of zone of 
inhibition was measured. Three technical 
replicates were performed in each test and 




Statistical analysis was done using SPSS 
software (version 21, SPSS Inc, Chicago, IL, 
USA). Normality and ANOVA were used to 





Biosynthesized silver nanoparticles 
 
Silver nanoparticles were synthesized from silver 
nitrate by C. albicans. The reaction started within 
2 – 4 h and the color of the solution turned to 
yellowish brown, indicating the synthesis of silver 
nanoparticles by C. albicans. 
  
Characteristics of silver nanoparticles  
 
The formation of silver nanoparticles by C. 
albicans was further determined using the UV–
visible spectroscopy, which was shown on the 
surface plasmon resonance bands. Figure 1 
demonstrated that the silver nanoparticles peak 
was observed at 300 – 800 nm and the silver 
nanoparticles contribute to the absorption bands 
at 420 nm in the UV–visible spectra.  UV–Vis 
spectra of aqueous silver nitrate solution (control) 
when monitored separately did not show any at 
300 – 800 nm. 
 
Figure 1:   The UV–visible spectra curve of silver 
nanoparticles synthesized by Candida albicans 
 
The SEM images and their corresponding 
particle size distributions of silver nanoparticles 
are shown in Figure 2. The SEM images and 
their size distributions revealed that, the mean 
diameters and standard deviation of silver 
nanoparticles were about 20 – 80 nm with the 
different morphologies. Electron microscopy data 
indicate that the extracellular particles produced. 
 
 
Figure 2.   a: Scanning electron microscopy image 
and b:  the particle size distribution for silver 
nanoparticles synthesized by Candida albicans 
 
Antibacterial activity  
 
The antibacterial activity of synthesized silver 
nanoparticles by cell biomass of C. albicans was 
tested against pathogenic microorganisms E. coli 
and S. aureus. The synthesized silver 
nanoparticles efficiently inhibited the growth of 
Gram negative and Gram positive bacteria. Our 
results demonstrated that the biosynthesized 
silver nanoparticles had more antimicrobial 
activity against S. aureus compared to E. coli. 
The zones of inhibition for S. aureus and E. coli 




All natural silver has been recognized as a 
nontoxic, safe inorganic antimicrobial agent for 
centuries. The extracellular synthesis of silver 
nanoparticles had been reported numerous from 
bacteria, yeasts, fungi, and algae [4]. The data 
obtained demonstrate the extracellular synthesis 
of silver nanoparticles using C. albicans. These 
findings are consistent with Waghmare et al [3] 
observations that silver nanoparticles could be 
synthesized by Candida species. Candida is a 
genus of yeasts and replicate quickly, therefore 
are easy to manipulate genetically to make them 
produce more desired substances for synthesis. 
C. albicans is harmless commensals or 
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endosymbiosis of hosts including humans; 
however, when mucosal barriers are disrupted or 
the immune system is compromised they can 
invade and cause disease [14]. Moreover, Di 
Giacomo et al [15] used growing cells of C. 
albicans in combination with carbon nanotubes to 
produce stable electrically conductive bio-nano-
composite tissue materials that have been used 
as temperature sensing elements.  
 
The appearance of brown color from colorless 
cell biomass of C. albicans suggested the 
formation of silver nanoparticles [3].  This color 
arises due to the surface plasmon resonance 
phenomenon, which monitored through the UV–
visible spectrum at 420 nm, indicating formation 
of silver nanoparticles [3,16].  
 
The SEM images of the particles thus obtained 
show different particle morphology with the size 
range of 20 – 80 nm. Evidence demonstrates 
that the morphology of nanoparticles is highly 
variable, and includes spherical, rod-like, 
decahedral, triangular, and platelet shapes. This 
could be due to correlation of the absorption 
spectrum for individual silver nanoparticles [17]. 
 
Antibacterial activity of synthesized silver 
nanoparticles was found to be inhibitory to both 
Gram negative and Gram positive bacteria. 
Interestingly, the synthesized silver nanoparticles 
have shown more antimicrobial activity against 
Gram positive bacteria than the Gram negative 
bacteria. The exact mechanism of interaction and 
penetration of silver nanoparticles inside the cell 
and their antibacterial effect remains to be 
identified [3,4,16,17]. Scientific evidence shows 
that smaller silver nanoparticles having a high 
definite surface area available for interaction 
would have more antibacterial activity than larger 
silver nanoparticles. Moreover, it is possible that 
silver nanoparticles not only interact with the 
surface of the membrane, but can also penetrate 
inside the bacteria. Furthermore, the electrostatic 
attraction between positively charged 
nanoparticles and negatively charged bacterial 
cell membranes could be responsible for the 
interactions between nanoparticles and bacterial 
cells [4,16,17].   
 
The antibacterial effects of silver nanoparticles 
may be associated with the characteristics of 
certain bacterial species [4,16,17].  Our result 
showed the inhibition zone diameters of S. 
aureus were longer than those of E. coli. This 
implies that biosynthesized silver nanoparticles 
by C. albicans had better antibacterial activity 
against Gram positive bacteria than Gram 
negative bacteria, which could probably be 
explained by their biochemical and physiological 
properties [18]. 
 
The hypothesized mechanisms of antibacterial 
activity of silver nanoparticles, mostly relate to 
disturbance of the integrity of the cell membrane 
and depletion of the levels of intracellular ATP, 
ROS production, and cellular uptake of Ag+ ions 
or nanoparticles, due to membrane poration, with 
consequent suppression of respiratory enzymes 
and electron transport components and through 
interference with DNA functions [8,19,20]. Nada 
et al [5] demonstrated the antibacterial activity of 
silver nanoparticles synthesized from S. aureus 
against human pathogenic bacteria methicillin 
resistant S. epidermidis and Streptococcus 
pyogenes and against Salmonella typhi and K. 
pneumoniae. Similarly, El-Shanshoury et al [9] 
reported antibacterial activity of silver 
nanoparticles synthesized from Escherichia coli, 
Bacillus subtilis, and S. thermophilus against E. 
coli, B. subtilis, S. typhimurium, K. pneumoniae, 
S. aureus, Pseudomonas aeruginosa and C. 
albicans.  
 
The molecular mechanisms of action of silver 
nanoparticles were investigated using E. coli as a 
model system by proteomic approach. Parallel 
proteomic investigations resulted in up-regulation 
in the expression of a panel of envelope and heat 
shock proteins, which are direct evidence of 
dissipation of the outer membrane of bacteria 




The findings of this study demonstrate the 
simple, safe, cost-effective and ecofriendly 
preparation of silver nanoparticles using yeast C. 
albicans. The biosynthesized nanoparticles 
showed potential antibacterial activity against 
Gram-negative and Gram-positive bacteria. 
Thus, application of biosynthesized silver 
nanoparticles may lead to the development of 
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